References
Cholera-Peru. MMWR 1991; 40: 108-10
Todd Weber J, Mintz E, Cañizares R, et al. Multiple-resistant epidemic cholera in Ecuador: transmission by water and seafood [abstract no. 944]. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy; 1992 Oct 11–14; Anaheim
Rohwedder R, Bergan T, Thorsteinsson S, et al. Transintestinal elimination of ciprofloxacin. Chemotherapy 1990; 36: 77–84
Crump B, Wise R, Dent J. Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents Chemother 1983; 24: 784–6
Brumfitt W, Franklin I, Grady D, et al. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother 1984; 26: 757–61
Bennish M, Salam M, Khan W, et al. Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial. Ann Intern Med 1992; 117: 727–34
Gotuzzo E, Carrillo C. Quinolones in typhoid fever. Quinolones Bulletin 1993; 3: 37–40
Gotuzzo E, Cieza J, Estremadoyro L, et al. Cholera: lessons from the epidemic in Peru. Infect Dis Clin North Am 1994; 8: 183–205
Isenberg H. Clinical microbiology procedures handbook. American Society for Microbiology: 1992
Ericsson C, DuPont H. Traveller’s diarrhoea: approaches to prevention and treatment. Clin Infect Dis 1993; 16: 616–26
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gotuzzo, E., Seas, C., Echevarria, J. et al. Oral Ciprofloxacin in the Treatment of Cholera. Drugs 49 (Suppl 2), 451–453 (1995). https://doi.org/10.2165/00003495-199500492-00132
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199500492-00132